Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

The Modern Armamentarium of Osteoporosis Therapies: Selection and Sequence

Session Description

Goal-directed treatment allows healthcare providers to recommend the best treatments for individual patients to prevent fractures. The goal-directed strategy considers fracture risk, fracture site and recency and bone mineral density. In contrast to the standard approach, same first treatment for all, treatment selection is tailored to an individual’s risk. This session will provide an update on fracture risk assessment, an overview of the relative efficacy of our current therapeutic armamentarium, and a new algorithm for selecting initial therapy based on the patient’s fracture risk and bone density.

Presentations in This Video

The Modern Armamentarium of Osteoporosis Therapies: Selection and Sequence

Gina Woods, MD

University of California, San Diego

Imminent Fracture Risk: Its Identification by BMD, FRAX, and Bone Turnover Markers

Richard Eastell, MBChB, MD

University of Sheffield

Treating to Target for Osteoporosis

Felicia Cosman, MD

Columbia University College of Physicians and Surgeons

Related Media